Abstracts

DOES TYPE OF PICK-UP POINT INFLUENCE 12-MONTH VIROLOGIC SUPPRESSION IN SOUTH AFRICA?

Background: South Africa’s Central Chronic Medicine Dispensing and Distribution (CCMDD) Program allows people living with HIV who are clinically stable the choice of collecting antiretroviral therapy (ART) at community pick-up points to increase convenience. Our objective was to assess the impact of community pick-up (vs. clinic-based ‘fast-track’ pick-up) on rates of virologic suppression 12 months…

METABOLIC HEALTH AND BONE DENSITY IN YOUTH LIVING WITH PERINATAL HIV

Background: Adverse metabolic profiles in adults living with HIV are associated with traditional risk factors, HIV viraemia and antiretroviral therapy (ART) with a paucity of data for youth living with perinatally acquired HIV (YPaHIV). As body mass index (BMI) impacts metabolic health and bone mineral density (BMD), we explored the relationship between markers of metabolic…

RECOVERY OF BONE MASS IN WOMEN ON DEPO-PROVERA AND TDF-BASED ART SWITCHED TO B/F/TAF

Background: We previously found that concomitant depot medroxyprogesterone acetate (DMPA-IM) contraceptive use resulted in a doubling of BMD loss in women living with HIV (WLWH) initiating tenofovir disoproxil fumarate (TDF) -containing ART in the BONE: CARE study. We sought to determine whether BMD would recover when these women switched to tenofovir alafenamide fumarate (TAF)-containing ART…

MATERNAL ART USE AND PRETERM DELIVERY: THE IMPACT OF DATA SOURCES AND DATA QUALITY

Background: Majority of studies investigating associations between maternal antiretroviral therapy (ART) and preterm delivery (PTD) are observational and subject to bias, which may contribute to heterogeneity in findings. We investigated the impact of participant selection, data source and data quality on observed associations between maternal ART and PTD. Methods: Data from 3 related data sources…

INTRAMUSCULAR CABOTEGRAVIR/RILPIVIRINE CONCENTRATIONS AFTER SWITCHING FROM EFAVIRENZ

Background: Intramuscular cabotegravir and rilpivirine (IM CAB/RPV) are used once viral load suppression is achieved on another antiretroviral regimen. While CAB/RPV are substrates of UGT1A1/CYP3A4, efavirenz induces these enzymes therefore switching from an efavirenz containing regimen to IM CAB/RPV could possibly result in a time window with suboptimal drug levels. The aim of this study…

WHAT INFLUENCES SWITCHING TO DTG/3TC VS B/F/TAF IN CLINICAL PRACTICE?

Background: Both B/F/TAF and DTG/3TC are recommended in treatment guidelines for both initial and switch therapy in people with HIV (PWH). Understanding clinical and socio-demographic drivers of switching to DTG/3TC or B/F/TAF and how PWH vary by regimen is critical when comparing outcomes. Methods: Retrospective study with Trio Health HIV Network EMR data. Eligibility: ≥18…